Related references
Note: Only part of the references are listed.Functional consequences of brain exposure to saturated fatty acids: From energy metabolism and insulin resistance to neuronal damage
Karina Sanchez-Alegria et al.
ENDOCRINOLOGY DIABETES & METABOLISM (2023)
Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease
Qiaoying Huang et al.
NEUROBIOLOGY OF DISEASE (2023)
ATP-releasing SWELL1 channel in spinal microglia contributes to neuropathic pain
Jiachen Chu et al.
SCIENCE ADVANCES (2023)
Role of de novo lipogenesis in inflammation and insulin resistance in Alzheimer's disease
Mohsin Ali Khan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)
Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Stephanie Kullmann et al.
DIABETES CARE (2022)
Diversity in sphingolipid metabolism across land plants
Tegan M. Haslam et al.
JOURNAL OF EXPERIMENTAL BOTANY (2022)
Lipid pathway dysfunction is prevalent in patients with Parkinson's disease
Jasmin Galper et al.
BRAIN (2022)
Compartmentalization of Sphingolipid metabolism: Implications for signaling and therapy
Daniel Canals et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Insulin action in the brain: cell types, circuits, and diseases
Wenqiang Chen et al.
TRENDS IN NEUROSCIENCES (2022)
α-Lipoic Acid Reduces Ceramide Synthesis and Neuroinflammation in the Hypothalamus of Insulin-Resistant Rats, While in the Cerebral Cortex Diminishes the β-Amyloid Accumulation
Mateusz Maciejczyk et al.
JOURNAL OF INFLAMMATION RESEARCH (2022)
Sphingosine-1-phosphate-lyase deficiency affects glucose metabolism in a way that abets oncogenesis
Sumaiya Y. Afsar et al.
MOLECULAR ONCOLOGY (2022)
Inside the diabetic brain: Insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies
Bhaskar Jyoti Dutta et al.
PHARMACOLOGICAL RESEARCH (2022)
Neuronal activity induces glucosylceramide that is secreted via exosomes for lysosomal degradation in glia
Liping Wang et al.
SCIENCE ADVANCES (2022)
Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Stephanie Kullmann et al.
DIABETES CARE (2022)
Cannabidiol-A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance
Tomasz Charytoniuk et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
Bart O. Roep et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Ceramide accumulation induces mitophagy and impairs β-oxidation in PINK1 deficiency
Melissa Vos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Prosaposin mediates inflammation in atherosclerosis
Mandy M. T. van Leent et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Sphingosine-1-Phosphate, Motor Severity, and Progression in Parkinson's Disease (MARK-PD)
Edzard Schwedhelm et al.
MOVEMENT DISORDERS (2021)
Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition
Yuan Yuan et al.
CELL RESEARCH (2021)
Sphingosine 1-phosphate metabolism and insulin signaling
Dominik Wigger et al.
CELLULAR SIGNALLING (2021)
Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction
Yoav Hadas et al.
CIRCULATION (2020)
Protection Against Insulin Resistance by Apolipoprotein M/Sphingosine-1-Phosphate
Makoto Kurano et al.
DIABETES (2020)
Hepatic insulin resistance induced by mitochondrial oxidative stress can be ameliorated by sphingosine 1-phosphate
Hongjuan Fang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods
Daan van Kruining et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Integrated Metabolomics and Proteomics Analysis Reveals Plasma Lipid Metabolic Disturbance in Patients With Parkinson's Disease
Ling Hu et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Central nervous pathways of insulin action in the control of metabolism and food intake
Stephanie Kullmann et al.
Lancet Diabetes & Endocrinology (2020)
Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes
Ruth Brauer et al.
BRAIN (2020)
High Glucosylceramides and Low Anandamide Contribute to Sensory Loss and Pain in Parkinson's Disease
Katharina Klatt-Schreiner et al.
MOVEMENT DISORDERS (2020)
Pathophysiology of Type 2 Diabetes Mellitus
Unai Galicia-Garcia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases
Tim Bartels et al.
SCIENCE (2020)
Time-response studies on development of cognitive deficits in an experimental model of insulin resistance
Anand Kamal Sachdeva et al.
CLINICAL NUTRITION (2019)
Regulation of Astrocyte Functions in Multiple Sclerosis
Michael A. Wheeler et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline
Yevgen Chornenkyy et al.
BRAIN PATHOLOGY (2019)
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease
Evandro F. Fang et al.
NATURE NEUROSCIENCE (2019)
CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondria! Fragmentation in Obesity
Philipp Hammerschmidt et al.
CELL (2019)
Brain Insulin Resistance and Hippocampal Plasticity: Mechanisms and Biomarkers of Cognitive Decline
Matteo Spinelli et al.
FRONTIERS IN NEUROSCIENCE (2019)
Microglia Biology: One Century of Evolving Concepts
Marco Prinz et al.
CELL (2019)
Age-related hyperinsulinemia leads to insulin resistance in neurons and cell-cycle-induced senescence
Hei-Man Chow et al.
NATURE NEUROSCIENCE (2019)
Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides
Varman T. Samuel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS
Chun-Cheih Chao et al.
CELL (2019)
The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders
Kinga Czubowicz et al.
MOLECULAR NEUROBIOLOGY (2019)
BRAIN GLUCOSE METABOLISM: INTEGRATION OF ENERGETICS WITH FUNCTION
Gerald A. Dienel
PHYSIOLOGICAL REVIEWS (2019)
Sphingolipids in the Pathogenesis of Parkinson's Disease and Parkinsonism
Guang Lin et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Acid sphingomyelinase promotes mitochondrial dysfunction due to glutamate-induced regulated necrosis
Sergei A. Novgorodov et al.
JOURNAL OF LIPID RESEARCH (2018)
Sphingolipids and their metabolism in physiology and disease
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link
Ying Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
Sphingolipidomics analysis of large clinical cohorts. Part 1: Technical notes and practical considerations
Wee Siong Chew et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Membrane-lipid homeostasis in a prodromal rat model of Alzheimer's disease: Characteristic profiles in ganglioside distributions during aging detected using MALDI imaging mass spectrometry
Sarah Caughlin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)
Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes
Brittany A. Law et al.
FASEB JOURNAL (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
Lactate in the brain: from metabolic end-product to signalling molecule
Pierre J. Magistretti et al.
NATURE REVIEWS NEUROSCIENCE (2018)
The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives
Andrea Huwiler et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
Daniel Stoessel et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain
Arpiar Saunders et al.
CELL (2018)
Discovery of 4-Benzyloxybenzo[d]isoxazole-3-amine Derivatives as Highly Selective and Orally Efficacious Human Sphingomyelin Synthase 2 Inhibitors that Reduce Chronic Inflammation in db/db Mice
Mingguang Mo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis
Giovanna Scapin et al.
NATURE (2018)
MECHANISMS OF INSULIN ACTION AND INSULIN RESISTANCE
Max C. Petersen et al.
PHYSIOLOGICAL REVIEWS (2018)
GPRC5B-Mediated Sphingomyelin Synthase 2 Phosphorylation Plays a Critical Role in Insulin Resistance
Yeon-Jeong Kim et al.
ISCIENCE (2018)
Sphingolipid metabolism in cancer signalling and therapy
Besim Ogretmen
NATURE REVIEWS CANCER (2018)
Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease
Isaura V. A. Martins et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
Yumiko V. Taguchi et al.
JOURNAL OF NEUROSCIENCE (2017)
The Vicious Circle of Hypometabolism in Neurodegenerative Diseases: Ways and Mechanisms of Metabolic Correction
Yuri Zilberter et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells
Samuela Cataldi et al.
MEDIATORS OF INFLAMMATION (2017)
Exploring the Association between Statin Use and the Risk of Parkinson's Disease: A Meta-Analysis of Observational Studies
Tahmina Nasrin Poly et al.
NEUROEPIDEMIOLOGY (2017)
FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing
Amitabh Das et al.
NEUROPHARMACOLOGY (2017)
Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation
Veit Rothhammer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Neuronal control of peripheral insulin sensitivity and glucose metabolism
Johan Ruud et al.
NATURE COMMUNICATIONS (2017)
High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson's Disease Patients
Jinzhi Zhang et al.
MEDICAL SCIENCE MONITOR (2017)
Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis
Robin B. Chan et al.
PLOS ONE (2017)
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease
Laurie A. Robak et al.
BRAIN (2017)
Brain metabolism in health, aging, and neurodegeneration
Simonetta Camandola et al.
EMBO JOURNAL (2017)
Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry
Ibrahim Kaya et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Hypothalamic roles of mTOR complex I: integration of nutrient and hormone signals to regulate energy homeostasis
Fang Hu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice
Masayuki Sugimoto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Adipocyte Ceramides Regulate Subcutaneous Adipose Browning, Inflammation, and Metabolism
Bhagirath Chaurasia et al.
Cell Metabolism (2016)
Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage
Rasoul Ghasemi et al.
PHARMACOLOGICAL RESEARCH (2016)
Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease
Stephen C. Cunnane et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice
Giuseppe Perruolo et al.
SCIENTIFIC REPORTS (2016)
Is type 2 diabetes related to leukoaraiosis? an updated review
A. Del Bene et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models
Erika Calvo-Ochoa et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2015)
SPHINGOSINE KINASE 2 AND SPHINGOSINE-1-PHOSPHATE PROMOTES MITOCHONDRIAL FUNCTION IN DOPAMINERGIC NEURONS OF MOUSE MODEL OF PARKINSON'S DISEASE AND IN MPP+-TREATED MN9D CELLS IN VITRO
M. Sivasubramanian et al.
NEUROSCIENCE (2015)
Insulin resistance in brain alters dopamine turnover and causes behavioral disorders
Andre Kleinridders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Protein Tyrosine Phosphatases in Hypothalamic Insulin and Leptin Signaling
Zhong-Yin Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Intranasal Insulin Enhanced Resting-State Functional Connectivity of Hippocampal Regions in Type 2 Diabetes
Hui Zhang et al.
DIABETES (2015)
Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer's Disease Pathogenesis
Ben Ellis et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Pathological roles of ceramide and its metabolites in metabolic syndrome and Alzheimer's disease
Kohei Yuyama et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Ceramide and the mitochondrial respiratory chain
Aviram Kogot-Levin et al.
BIOCHIMIE (2014)
PS Dependent APP Cleavage Regulates Glucosylceramide Synthase and is Affected in Alzheimer's Disease
Marcus O. W. Grimm et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Enhancement of Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
Vera Novak et al.
DIABETES CARE (2014)
Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype
Susann Fayyaz et al.
DIABETOLOGIA (2014)
Brain imaging in type 2 diabetes
Manon Brundel et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
The key role of sphingosine kinases in the molecular mechanism of neuronal cell survival and death in an experimental model of Parkinson's disease
Joanna A. Pyszko et al.
FOLIA NEUROPATHOLOGICA (2014)
Ceramides and Glucosylceramides Are Independent Antagonists of Insulin Signaling
Jose A. Chavez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
Anthony H. V. Schapira et al.
LANCET (2014)
Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions
Noemi Fabelo et al.
NEUROBIOLOGY OF AGING (2014)
High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice
Steven E. Arnold et al.
NEUROBIOLOGY OF DISEASE (2014)
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis
Timothy A. Couttas et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration
A. I. Duarte et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases
Li Liu et al.
NEUROBIOLOGY OF AGING (2013)
Sugar for the brain: the role of glucose in physiological and pathological brain function
Philipp Mergenthaler et al.
TRENDS IN NEUROSCIENCES (2013)
A Ceramide-Centric View of Insulin Resistance
Jose A. Chavez et al.
CELL METABOLISM (2012)
Ceramide kinase deficiency improves diet-induced obesity and insulin resistance
Susumu Mitsutake et al.
FEBS LETTERS (2012)
Increased Ceramide in Brains with Alzheimer's and Other Neurodegenerative Diseases
Valery Filippov et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease
Robin B. Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-β by Microglia
Kohei Yuyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-α
Brian M. Barth et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans
Gusheng Wu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Sphingolipids: Critical players in Alzheimer's disease
Gerhild van Echten-Deckert et al.
PROGRESS IN LIPID RESEARCH (2012)
Insulin resistance in the nervous system
Bhumsoo Kim et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Alfred H. Merrill
CHEMICAL REVIEWS (2011)
Reducing Plasma Membrane Sphingomyelin Increases Insulin Sensitivity
Zhiqiang Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
Xianlin Han et al.
PLOS ONE (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Deregulation of sphingolipid metabolism in Alzheimer's disease
Xingxuan He et al.
NEUROBIOLOGY OF AGING (2010)
Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome
Guang Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
FTY720 Rescue Therapy in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis: Expression of Central Nervous System Genes and Reversal of Blood-Brain-Barrier Damage
Carolyn A. Foster et al.
BRAIN PATHOLOGY (2009)
Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent
C. A. Grillo et al.
BRAIN RESEARCH (2009)
Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance
Jacob M. Haus et al.
DIABETES (2009)
Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis
Lascelles E. Lyn-Cook et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Brain Insulin-Like Growth Factor and Neurotrophin Resistance in Parkinson's Disease and Dementia with Lewy Bodies: Potential Role of Manganese Neurotoxicity
Ming Tong et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Clustering and Lateral Concentration of Raft Lipids by the MAL Protein
Lee Goldstein Magal et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The sphingolipid salvage pathway in ceramide metabolism and signaling
Kazuyuki Kitatani et al.
CELLULAR SIGNALLING (2008)
Sphingolipids, insulin resistance, and metabolic disease:: New insights from in vivo manipulation of sphingolipid metabolism
William L. Holland et al.
ENDOCRINE REVIEWS (2008)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Genotype-related changes of ganglioside composition in brain regions of transgenic mouse models of Alzheimer's disease
Laurence Barrier et al.
NEUROBIOLOGY OF AGING (2007)
Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes
Hongmei Zhao et al.
DIABETES (2007)
Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity
Johannes M. Aerts et al.
DIABETES (2007)
Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: A shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
Pavel Katsel et al.
NEUROCHEMICAL RESEARCH (2007)
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
William L. Holland et al.
CELL METABOLISM (2007)
Synapse formation and function is modulated by the amyloid precursor protein
Christina Priller et al.
JOURNAL OF NEUROSCIENCE (2006)
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?
E Steen et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
TNF alpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3
K Kabayama et al.
GLYCOBIOLOGY (2005)
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease
RG Cutler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Characterization of serine palmitoyltransferase in normal human tissues
AD Batheja et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
Enhanced insulin sensitivity in mice lacking ganglioside GM3
T Yamashita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins
LJ Siskind et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ceramide kinase, a novel lipid kinase - Molecular cloning and functional characterization
M Sugiura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ceramide-induced sustained depression of synaptic currents mediated by ionotropic glutamate receptors in the hippocampus: An essential role of postsynaptic protein phosphatases
SN Yang
NEUROSCIENCE (2000)
Share Paper
